The 32nd Annual North Central Heart Cardiac Symposium will be Friday, November 7, 2014 at the Sioux Falls Convention Center. Call 605-977-5311 for more information or register online using the link above.
7:55 – 8:00 a.m. Welcome
8:00 – 8:45 a.m. Medications vs. Lifestyle
Joel Kahn, MD, FACC, FCP, FSCAI
Invasive, Nuclear, and Preventative Cardiologist, Michigan Healthcare Professionals, PC, Southfield, MI
Author of The Holistic Heart Book – A Preventative Cardiologist’s Guide to Halt Heart Disease Now
Objective: Compare the use of cardiovascular medications versus life style changes in controlling cardiovascular disease.
8:45 – 9:15 a.m. PVCs and Cardiomyopathy
Jonathon Adams, MD, Cardiologist, North Central Heart
Objective: Identify the treatment for Premature Ventricular Contractions (PVCs) and PVC Cardiomyopathy.
9:15 – 9:45 a.m. What to Do With Abnormal Coronary
Joel Kahn, MD, FACC, FCP, FSCAI
Objective: Describe the treatment of abnormal coronary calcium scores for patients with moderate cardiovascular risks.
9:45 – 10:00 a.m. Discussion Panel
Joel Kahn, MD, FACC, FCP, FSCAI and Jonathon Adams, MD
10:00 – 10:20 a.m. Break and Vendors
10:20 – 11:05 a.m. Screening Athletes for Risks of
Sudden Cardiac Deaths
Mark Link, MD, Cardiologist, Tufts Medical Center, Boston,
Objective: Discuss the pros and cons of screening athletes for sudden cardiac deaths.
11:05 – 11:50 a.m. TAVR
Christopher Paa, MD, FACC, Cardiologist, North Central Heart and Tommy Reynolds, MD, FACS, Cardiovascular Surgeon, North Central Heart
Objective: Describe the Transcatheter Aortic Valve Replacement (TAVR) procedure and patient criteria.
11:50 – 12:05 p.m. Discussion Panel
Mark Link, MD, Christopher Paa, MD, FACC, and
Tommy Reynolds, MD, FACS
12:05 – 1:05 p.m. Lunch/Vendors
1:05 – 1:35 p.m. Hypertrophic Cardiomyopathy –
Assessing Genetic Testing and Treating Long QT
Mark Link, MD, Cardiologist, Tufts Medical Center, Boston, MA
Objective: Describe the diagnosis and treatment of Hypertrophic Cardiomyopathy in athletes.
1:35 – 2:05 p.m. Chronic Total Occlusion
Raymond Allen, MD, FACC, Cardiologist, North Central Heart
Objective: Describe the treatment options for Chronic Total Occlusion and their indications.
2:05 – 2:15 p.m. Discussion Panel
Mark Link, MD and Raymond Allen, MD, FACC
2:15 – 2:35 p.m. Break/Vendors
2:35 – 4:15 p.m. Advanced Biomarker Testing, A Case
Tara Dall, MD, FNLA, Board Certified Lipidologist, Health Diagnostic Laboratory
Objective: Examine the use of biomarkers in the prevention of cardiovascular disease.
4:15 – 4:55 p.m. Red Blood Cell Fatty Acid Patterns and
Cardiovascular Risk Assessment
William Harris, PhD, President, OmegaQuant
Objective: Discuss RBC levels of omega 3 and trans fatty acids in the reduction of cardiovascular disease risk.
4:55 – 5:00 p.m. Evaluation and Wrap-up
Continuing Education for Sessions 1, 2 & 3
Avera is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Avera designates this educational activity for a maximum of 4.9 AMA PRA Category 1 Credits(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Avera Health is an Approved Provider of continuing nursing education by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
A total of 4.9 contact hours can be received upon completion of this education activity. Attendance at the entire educational activity is required to receive contact hours.
The American Socity of Radiologic Technologists has approved the following presentations for Category A credit:
PVS and Cardiomyopathy 0.5 Credit
What to do with Abnormal Coronary Calcium Scores 0.5 Credit
Screening Athletes for Risks of Sudden Cardiac Deaths 1.0 Credit
TAVR 1.0 Credit
Hypertrophic Cardiomyopathy - Assessing Genetic Testing and Treating Long QT 0.5 Credit
Chronic Total Occlusion 0.5 Credit
Continuing Education for Session 4
Presentations have been approved by the AAFP. Dr. Tara Dall’s presentation has been designated for 1.6 AAFP credits. Dr William Harris’ presentation has been designated for 0.6 AAFP credits.